Consun Pharmaceutical proposes governance overhaul to align with modern practices

Consun Pharmaceutical Group Limited announced on November 6, 2025, proposed amendments to its existing memorandum and articles of association. These changes aim to enable the company to hold and dispose of repurchased shares as treasury shares, in accordance with applicable Cayman Islands laws and recent listing rules amendments concerning treasury shares. The amendments also include other "housekeeping changes."

The board proposes adopting a new "third amended and restated memorandum and articles of association" to reflect these updates. The proposed amendments and the adoption of the new memorandum and articles of association are contingent upon shareholder approval via a special resolution at an extraordinary general meeting.

A circular detailing these proposals and the EGM notice will be dispatched to shareholders in due course. The announcement was made pursuant to Rule 13.51(1) of the listing rules by Consun Pharmaceutical Group Limited, with An Meng serving as chairman of the board.